Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2023 | Orbital Therapeutics | $270.0M Series A | ARCH Venture Partners | Andreessen Horowitz, Nextech Invest, Section 32, Versant Ventures, a16z Bio + Health, Abu Dhabi Growth Fund, Agent Capital, Alexandria Venture Investments, Casdin Capital, Exor, Heritage Medical Systems, iGlobe Partners, Invus, Newpath Partners, Redmile Group |